Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection

Journal of Virology

Volumn 84, Issue 19, 2010, Pages 9677-9684

  Maginnis, Melissa S ^a   Haley, Sheila A ^a   Gee, Gretchen V ^a   Atwood, Walter J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOSACCHARIDE; SEROTONIN 2A RECEPTOR; TUNICAMYCIN; GLYCOPEPTIDASE; HYBRID PROTEIN; N ACETYLNEURAMINIC ACID; PRIMER DNA; SIALIDASE; VIRUS RECEPTOR;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; GENE MUTATION; GLYCOSYLATION; HYPOTHESIS; JC VIRUS; JC VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; BINDING SITE; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS;

JC POLYOMAVIRUS; POLYOMAVIRUS;

BASE SEQUENCE; BINDING SITES; CELL LINE; DNA PRIMERS; GLYCOSYLATION; HOST-PATHOGEN INTERACTIONS; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MUTAGENESIS, SITE-DIRECTED; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUNICAMYCIN;

EID: 77956856952     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00978-10     Document Type: Article

References (48)

1. Astrom, K. E., E. L. Mancall, and E. P. Richardson, Jr. 1958. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 81:93-111.
2. Backstrom, J. R., R. S. Westphal, H. Canton, and E. Sanders-Bush. 1995. Identification of rat serotonin 5-HT2C receptors as glycoproteins containing N-linked oligosaccharides. Brain Res. Mol. Brain Res. 33:311-318.
3. Bockaert, J., S. Claeysen, C. Becamel, A. Dumuis, and P. Marin. 2006. Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res. 326:553-572.
4. Bonhaus, D. W., C. Bach, A. DeSouza, F. H. Salazar, B. D. Matsuoka, P. Zuppan, H. W. Chan, and R. M. Eglen. 1995. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br. J. Pharmacol. 115:622-628.
5. Carson, K. R., A. M. Evens, E. A. Richey, T. M. Habermann, D. Focosi, J. F. Seymour, J. Laubach, S. D. Bawn, L. I. Gordon, J. N. Winter, R. R. Furman, J. M. Vose, A. D. Zelenetz, R. Mamtani, D. W. Raisch, G. W. Dorshimer, S. T. Rosen, K. Muro, N. R. Gottardi-Littell, R. L. Talley, O. Sartor, D. Green, E. O. Major, and C. L. Bennett. 2009. Progressive multifocal leuko-encephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113:4834-4840.
6. Cettomai, D., and J. C. McArthur. 2009. Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch. Neurol. 66:255-258.
7. Chapagain, M. L., L. Sumibcay, U. Gurjav, P. H. Kaufusi, R. E. Kast, and V. R. Nerurkar. 2008. Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells. J. Neurovirol. 14:448-454.
8. Chapagain, M. L., S. Verma, F. Mercier, R. Yanagihara, and V. R. Nerurkar. 2007. Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A. Virology 364:55-63.
9. Chesters, P. M., J. Heritage, and D. J. McCance. 1983. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J. Infect. Dis. 147:676-684.
10. Cinque, P., I. J. Koralnik, S. Gerevini, J. M. Miro, and R. W. Price. 2009. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect. Dis. 9:625-636.
11. Dorries, K. 1998. Molecular biology and pathogenesis of human polyomavirus infections. Dev. Biol. Stand. 94:71-79.
12. Dorries, K., and V. ter Meulen. 1983. Progressive multifocal leucoencephalopathy: detection of papovavirus JC in kidney tissue. J. Med. Virol. 11:307-317.
13. Dorries, K., E. Vogel, S. Gunther, and S. Czub. 1994. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198:59-70. (Pubitemid 124018762)
14. Dubois, V., H. Dutronc, M. E. Lafon, V. Poinsot, J. L. Pellegrin, J. M. Ragnaud, A. M. Ferrer, and H. J. Fleury. 1997. Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. J. Clin. Microbiol. 35:2288-2292.
15. Dubois, V., M. E. Lafon, J. M. Ragnaud, J. L. Pellegrin, F. Damasio, C. Baudouin, V. Michaud, and H. J. Fleury. 1996. Detection of JC virus DNA in the peripheral blood leukocytes of HIV-infected patients. AIDS 10:353-358.
16. Dugan, A. S., M. L. Gasparovic, and W. J. Atwood. 2008. Direct correlation between sialic acid binding and infection of cells by two human polyomaviruses (JC virus and BK virus). J. Virol. 82:2560-2564.
17. Dutton, A. C., A. N. Massoura, T. J. Dover, N. A. Andrews, and N. M. Barnes. 2008. Identification and functional significance of N-glycosylation of the 5-ht5A receptor. Neurochem Int. 52:419-425.
18. Elphick, G. F., W. Querbes, J. A. Jordan, G. V. Gee, S. Eash, K. Manley, A. Dugan, M. Stanifer, A. Bhatnagar, W. K. Kroeze, B. L. Roth, and W. J. Atwood. 2004. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380-1383.
19. Fleischmann, R. M. 2009. Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis. Arthritis Rheum. 60:3225-3228.
20. Houff, S. A., E. O. Major, D. A. Katz, C. V. Kufta, J. L. Sever, S. Pittaluga, J. R. Roberts, J. Gitt, N. Saini, and W. Lux. 1988. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N. Engl. J. Med. 318:301-305.
21. Kean, J. M., S. Rao, M. Wang, and R. L. Garcea. 2009. Seroepidemiology of human polyomaviruses. PLoS Pathog. 5:e1000363.
22. Khalili, K., and M. K. White. 2006. Human demyelinating disease and the polyomavirus JCV. Mult. Scler. 12:133-142.
23. Kishida, S. 2007. Progressive multifocal leukoencephalopathy - epidemiology, clinical pictures, diagnosis and therapy. Brain Nerve 59:125-137.
24. Kleinschmidt-DeMasters, B. K., and K. L. Tyler. 2005. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 353:369-374.
25. Knowles, W. A., P. Pipkin, N. Andrews, A. Vyse, P. Minor, D. W. Brown, and E. Miller. 2003. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71:115-123.
26. Langer-Gould, A., S. W. Atlas, A. J. Green, A. W. Bollen, and D. Pelletier. 2005. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353:375-381.
27. Lanzafame, M., S. Ferrari, E. Lattuada, F. Corsini, R. Deganello, S. Vento, and E. Concia. 2009. Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy. Infez. Med. 17:35-37.
28. Linda, H., A. von Heijne, E. O. Major, C. Ryschkewitsch, J. Berg, T. Olsson, and C. Martin. 2009. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N. Engl. J. Med. 361:1081-1087.
29. Liu, C. K., and W. J. Atwood. 2001. Propagation and assay of the JC virus. Methods Mol. Biol. 165:9-17.
30. Liu, C. K., A. P. Hope, and W. J. Atwood. 1998. The human polyomavirus, JCV, does not share receptor specificity with SV40 on human glial cells. J. Neurovirol. 4:49-58.
31. Liu, C. K., G. Wei, and W. J. Atwood. 1998. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. J. Virol. 72:4643-4649.
32. Major, E. O., K. Amemiya, C. S. Tornatore, S. A. Houff, and J. R. Berger. 1992. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 5:49-73.
33. Molloy, E. S., and L. H. Calabrese. 2008. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk? Autoimmun Rev. 8:144-146.
34. Monk, S. A., J. M. Williams, A. G. Hope, and N. M. Barnes. 2004. Identification and importance of N-glycosylation of the human 5-hydroxytryptamine3A receptor subunit. Biochem. Pharmacol. 68:1787-1796.
35. O'Hara, B. A., and W. J. Atwood. 2008. Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus. Virus Res. 132:97-103.
36. Quirk, P. L., S. Rao, B. L. Roth, and R. E. Siegel. 2004. Three putative N-glycosylation sites within the murine 5-HT3A receptor sequence affect plasma membrane targeting, ligand binding, and calcium influx in heterologous mammalian cells. J. Neurosci. Res. 77:498-506.
37. Rahmlow, M., E. A. Shuster, J. Dominik, H. G. Deen, Jr., D. W. Dickson, A. J. Aksamit, Jr., H. A. Robles, and W. D. Freeman. 2008. Leflunomide- associated progressive multifocal leukoencephalopathy. Arch. Neurol. 65: 1538-1539.
38. Schaumburg, C., B. A. O'Hara, T. E. Lane, and W. J. Atwood. 2008. Human embryonic stem cell-derived oligodendrocyte progenitor cells express the serotonin receptor and are susceptible to JC virus infection. J. Virol. 82: 8896-8899.
39. Shah, K. V., B. N. Fields, D. M. Knipe, and P. M. Howley. 1996. Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
40. Silverman, L., and L. J. Rubinstein. 1965. Electron microscopic observations on a case of progressive multifocal leukoencephalopathy. Acta Neuropathol. 5:215-224.
41. Straumann, N., A. Wind, T. Leuenberger, and T. Wallimann. 2006. Effects of N-linked glycosylation on the creatine transporter. Biochem. J. 393:459-469. (Pubitemid 43099085)
42. Sunyaev, S. R., A. Lugovskoy, K. Simon, and L. Gorelik. 2009. Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML). PLoS Genet. 5:e1000368.
43. Trombetta, E. S. 2003. The contribution of N-glycans and their processing in the endoplasmic reticulum to glycoprotein biosynthesis. Glycobiology 13: 77R-91R.
44. Van Assche, G., M. Van Ranst, R. Sciot, B. Dubois, S. Vermeire, M. Noman, J. Verbeeck, K. Geboes, W. Robberecht, and P. Rutgeerts. 2005. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N. Engl. J. Med. 353:362-368.
45. Verma, S., K. Cikurel, I. J. Koralnik, S. Morgello, C. Cunningham-Rundles, Z. R. Weinstein, C. Bergmann, and D. M. Simpson. 2007. Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J. Infect. Dis. 196:709-711.
46. Vulliemoz, S., F. Lurati-Ruiz, F. X. Borruat, J. Delavelle, I. J. Koralnik, T. Kuntzer, J. Bogousslavsky, F. Picard, T. Landis, and R. A. Du Pasquier. 2006. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J. Neurol. Neurosurg. Psychiatry 77: 1079-1082.
47. Wenning, W., A. Haghikia, J. Laubenberger, D. B. Clifford, P. F. Behrens, A. Chan, and R. Gold. 2009. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N. Engl. J. Med. 361:1075-1080.
48. Zurhein, G., and S. M. Chou. 1965. Particles resembling papova viruses in human cerebral demyelinating disease. Science 148:1477-1479.